Temasek Holdings and TPG-supported eye care services Dr. Agarwal Health Care has filed a draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to acquire funds through an initial public offering.
The IPO, with a face value of Rs 1 per equity share, consists of a fresh issue of up to Rs 300 crore and an offer for sale of up to 69,568,204 equity shares by the promoter and other selling shareholders.
The deal also includes a subscription reservation for qualified employees.
The firm, in agreement with the book-running lead managers, may consider a pre-IPO placement of specified securities not exceeding 20% of the size of the new issue. If such a placement is accomplished, the new issue size will be lowered.
The offer is being made through the book-building process, with no more than 50% of the net offer available for proportionate allocation to qualified institutional buyers, no less than 15% available for allocation to non-institutional bidders, and no less than 35% available for allocation to retail individual bidders.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.